Select a section from the left sidebar
1,14-dibromotetradecane
- Family: Plantae - Annonaceae
- Kingdom: Plantae
- Class: Essential Oil
Canonical Smiles | BrCCCCCCCCCCCCCCBr |
---|---|
InChI | InChI=1S/C14H28Br2/c15-13-11-9-7-5-3-1-2-4-6-8-10-12-14-16/h1-14H2 |
InChIKey | SDENLXLNLFKRAR-UHFFFAOYSA-N |
Formula | C14H28Br2 |
HBA | 0 |
HBD | 0 |
MW | 356.19 |
Rotatable Bonds | 13 |
TPSA | 0.0 |
LogP | 6.46 |
Number Rings | 0 |
Number Aromatic Rings | 0 |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Fraction CSP3 | 1.0 |
Exact Mass | 354.06 |
Number of Lipinski Rule Violations | 1 |
# | Species | Family | Kingdom | NCBI Taxonomy ID |
---|---|---|---|---|
1 | Monanthotaxis littoralis | Annonaceae | Plantae | 2231816 |
Showing of synonyms
1,14-dibromotetradecane
Tetradecane, 1,14-dibromo-
Tetradecamethylene dibromide
EINECS 253-628-4
M7FH2T4N5G
UNII-M7FH2T4N5G
DTXSID3068049
DTXCID2039388
253-628-4
Sdenlxlnlfkrar-uhfffaoysa-n
37688-96-3
MFCD00045049
SCHEMBL4178961
1,14-Dibromotetradecane, 97%
BBL103093
STL556903
AKOS017342822
BS-27965
SY316628
DB-049173
CS-0162836
NS00030268
H11742
No compound-protein relationship available.
No scaffolds available.
Antifungal
Absorption
- Caco-2 (logPapp)
- -5.0
- Human Oral Bioavailability 20%
- Non-Bioavailable
- Human Intestinal Absorption
- Absorbed
- Madin-Darby Canine Kidney
- -4.49
- Human Oral Bioavailability 50%
- Bioavailable
- P-Glycoprotein Inhibitor
- Non-Inhibitor
- P-Glycoprotein Substrate
- Non-Substrate
- Skin Permeability
- -3.64
Distribution
- Blood-Brain Barrier (CNS)
- -
- Blood-Brain Barrier
- Penetrable
- Fraction Unbound (Human)
- 1.9
- Plasma Protein Binding
- 1.74
- Steady State Volume of Distribution
- -
Metabolism
- Breast Cancer Resistance Protein
- Inhibitor
- CYP 1A2 Inhibitor
- Non-Inhibitor
- CYP 1A2 Substrate
- Substrate
- CYP 2C19 Inhibitor
- Inhibitor
- CYP 2C19 Substrate
- Non-Substrate
- CYP 2C9 Inhibitor
- Inhibitor
- CYP 2C9 Substrate
- Non-Substrate
- CYP 2D6 Inhibitor
- Non-Inhibitor
- CYP 2D6 Substrate
- Non-Substrate
- CYP 3A4 Inhibitor
- Non-Inhibitor
- CYP 3A4 Substrate
- Non-Substrate
- OATP1B1
- Non-Inhibitor
- OATP1B3
- Non-Inhibitor
Excretion
- Clearance
- 6.93
- Organic Cation Transporter 2
- Non-Inhibitor
- Half-Life of Drug
- -
Toxicity
- AMES Mutagenesis
- Safe
- Avian
- Safe
- Bee
- Safe
- Bioconcentration Factor
- 1.84
- Biodegradation
- Safe
- Carcinogenesis
- Safe
- Crustacean
- Toxic
- Liver Injury I (DILI)
- Safe
- Eye Corrosion
- Toxic
- Eye Irritation
- Toxic
- Maximum Tolerated Dose
- 1.73
- Liver Injury II
- Safe
- hERG Blockers
- Safe
- Daphnia Maga
- 5.43
- Micronucleos
- Safe
- NR-AhR
- Safe
- NR-AR
- Safe
- NR-AR-LBD
- Safe
- NR-Aromatase
- Safe
- NR-ER
- Safe
- NR-ER-LBD
- Safe
- NR-GR
- Safe
- NR-PPAR-gamma
- Safe
- NR-TR
- Safe
- T. Pyriformis
- 7.41
- Rat (Acute)
- 2.49
- Rat (Chronic Oral)
- 2.11
- Fathead Minnow
- 4.42
- Respiratory Disease
- Safe
- Skin Sensitisation
- Toxic
- SR-ARE
- Safe
- SR-ATAD5
- Safe
- SR-HSE
- Safe
- SR-MMP
- Safe
- SR-p53
- Safe
General Properties
- Boiling Point
- 351.19
- Hydration Free Energy
- -0.3
- Log(D) at pH=7.4
- 4.62
- Log(P)
- 7.96
- Log S
- -6.67
- Log(Vapor Pressure)
- -4.69
- Melting Point
- 48.3
- pKa Acid
- 11.04
- pKa Basic
- 6.27
No predicted protein targets found for this compound.